Sinocare Inc (300298) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.072x

Based on the latest financial reports, Sinocare Inc (300298) has a cash flow conversion efficiency ratio of 0.072x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥264.19 Million ≈ $38.66 Million USD) by net assets (CN¥3.67 Billion ≈ $537.71 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Sinocare Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Sinocare Inc - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Sinocare Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Sinocare Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sinocare Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Beijing Jingyuntong Technology Co Ltd
SHG:601908
0.051x
Shenzhen Das Intellitech Co Ltd
SHE:002421
-0.038x
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
0.014x
Catalyst Metals Ltd
AU:CYL
0.205x
Huadian Heavy Industries Co
SHG:601226
-0.055x
Advantage Oil & Gas Ltd.
TO:AAV
0.048x
Vulcan Energy Resources Limited
AU:VUL
-0.049x
Financial Street Holdings Co Ltd
SHE:000402
0.018x

Annual Cash Flow Conversion Efficiency for Sinocare Inc (2008–2024)

The table below shows the annual cash flow conversion efficiency of Sinocare Inc from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see 300298 market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥3.77 Billion
≈ $551.61 Million
CN¥631.29 Million
≈ $92.38 Million
0.167x -20.94%
2023-12-31 CN¥3.47 Billion
≈ $507.88 Million
CN¥735.15 Million
≈ $107.57 Million
0.212x +40.36%
2022-12-31 CN¥3.14 Billion
≈ $460.00 Million
CN¥474.39 Million
≈ $69.42 Million
0.151x -12.21%
2021-12-31 CN¥2.79 Billion
≈ $408.61 Million
CN¥480.03 Million
≈ $70.24 Million
0.172x -6.63%
2020-12-31 CN¥2.74 Billion
≈ $401.11 Million
CN¥504.64 Million
≈ $73.84 Million
0.184x -6.72%
2019-12-31 CN¥2.65 Billion
≈ $387.62 Million
CN¥522.81 Million
≈ $76.50 Million
0.197x +62.15%
2018-12-31 CN¥2.62 Billion
≈ $383.83 Million
CN¥319.27 Million
≈ $46.72 Million
0.122x -30.65%
2017-12-31 CN¥1.39 Billion
≈ $203.34 Million
CN¥243.89 Million
≈ $35.69 Million
0.176x +10.25%
2016-12-31 CN¥1.28 Billion
≈ $186.99 Million
CN¥203.42 Million
≈ $29.77 Million
0.159x +62.46%
2015-12-31 CN¥1.24 Billion
≈ $181.47 Million
CN¥121.52 Million
≈ $17.78 Million
0.098x -28.90%
2014-12-31 CN¥1.11 Billion
≈ $162.61 Million
CN¥153.15 Million
≈ $22.41 Million
0.138x +13.95%
2013-12-31 CN¥946.01 Million
≈ $138.43 Million
CN¥114.42 Million
≈ $16.74 Million
0.121x -20.83%
2012-12-31 CN¥845.18 Million
≈ $123.68 Million
CN¥129.12 Million
≈ $18.89 Million
0.153x -68.09%
2011-12-31 CN¥179.51 Million
≈ $26.27 Million
CN¥85.93 Million
≈ $12.57 Million
0.479x -34.81%
2010-12-31 CN¥91.35 Million
≈ $13.37 Million
CN¥67.08 Million
≈ $9.82 Million
0.734x -29.18%
2009-12-31 CN¥41.49 Million
≈ $6.07 Million
CN¥43.03 Million
≈ $6.30 Million
1.037x +136.80%
2008-12-31 CN¥17.42 Million
≈ $2.55 Million
CN¥7.63 Million
≈ $1.12 Million
0.438x --

About Sinocare Inc

SHE:300298 China Medical Devices
Market Cap
$1.19 Billion
CN¥8.11 Billion CNY
Market Cap Rank
#8334 Global
#2035 in China
Share Price
CN¥14.48
Change (1 day)
-1.16%
52-Week Range
CN¥14.48 - CN¥23.46
All Time High
CN¥47.34
About

Sinocare Inc. engages in the development, manufacture, and marketing of rapid diagnosis testing products primarily in the People's Republic of China. It offers blood glucose and pressure monitors; point of care testing products; digital management tool solutions; non-invasive screening products; and PTS and Trividia products. The company provides its products for the patients with chronic disease… Read more